402 related articles for article (PubMed ID: 28322415)
41. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
Sacha GL; Lam SW; Wang L; Duggal A; Reddy AJ; Bauer SR
Crit Care Med; 2022 Apr; 50(4):614-623. PubMed ID: 34582425
[TBL] [Abstract][Full Text] [Related]
42. Clinical management for patients admitted to a critical care unit with severe sepsis or septic shock.
Cheung WK; Chau LS; Mak II; Wong MY; Wong SL; Tiwari AF
Intensive Crit Care Nurs; 2015 Dec; 31(6):359-65. PubMed ID: 26292920
[TBL] [Abstract][Full Text] [Related]
43. Comparison of Heart Rate After Phenylephrine vs Norepinephrine Initiation in Patients With Septic Shock and Atrial Fibrillation.
Law AC; Bosch NA; Peterson D; Walkey AJ
Chest; 2022 Oct; 162(4):796-803. PubMed ID: 35526604
[TBL] [Abstract][Full Text] [Related]
44. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis.
Lindenauer PK; Rothberg MB; Nathanson BH; Pekow PS; Steingrub JS
Crit Care Med; 2010 Apr; 38(4):1101-7. PubMed ID: 20154607
[TBL] [Abstract][Full Text] [Related]
45. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Laderchi A; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2008; 12(6):R143. PubMed ID: 19017409
[TBL] [Abstract][Full Text] [Related]
46. Norepinephrine combined with phenylephrine versus norepinephrine in patients with septic shock: a retrospective cohort study.
He D; Hu H; Hong L; Zhang L; Lu X; Gu WJ; Lyu J; Yin H
BMC Infect Dis; 2023 Apr; 23(1):221. PubMed ID: 37029365
[TBL] [Abstract][Full Text] [Related]
47. Use of heptaminol hydrochloride for catecholamine weaning in septic shock.
Bahloul M; Chaari A; Ben Mbarek MN; Kallel H; Bouaziz M
Am J Ther; 2012 Jan; 19(1):e8-17. PubMed ID: 20720484
[TBL] [Abstract][Full Text] [Related]
48. Fever control using external cooling in septic shock: a randomized controlled trial.
Schortgen F; Clabault K; Katsahian S; Devaquet J; Mercat A; Deye N; Dellamonica J; Bouadma L; Cook F; Beji O; Brun-Buisson C; Lemaire F; Brochard L
Am J Respir Crit Care Med; 2012 May; 185(10):1088-95. PubMed ID: 22366046
[TBL] [Abstract][Full Text] [Related]
49. Timing of vasopressor initiation and mortality in septic shock: a cohort study.
Beck V; Chateau D; Bryson GL; Pisipati A; Zanotti S; Parrillo JE; Kumar A;
Crit Care; 2014 May; 18(3):R97. PubMed ID: 24887489
[TBL] [Abstract][Full Text] [Related]
50. Comparison of Vasopressor Duration in Septic Shock Patients With and Without Cirrhosis.
Durst MM; Eitzen EA; Benken ST
Ann Pharmacother; 2021 Aug; 55(8):970-979. PubMed ID: 33327736
[TBL] [Abstract][Full Text] [Related]
51. Relative Bradycardia in Patients With Septic Shock Requiring Vasopressor Therapy.
Beesley SJ; Wilson EL; Lanspa MJ; Grissom CK; Shahul S; Talmor D; Brown SM
Crit Care Med; 2017 Feb; 45(2):225-233. PubMed ID: 27618277
[TBL] [Abstract][Full Text] [Related]
52. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
Svoboda P; Scheer P; Kantorová I; Doubek J; Dudra J; Radvan M; Radvanova J
Hepatogastroenterology; 2012 Jun; 59(116):1043-7. PubMed ID: 22580654
[TBL] [Abstract][Full Text] [Related]
53. Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock.
Thomas-Rueddel DO; Poidinger B; Weiss M; Bach F; Dey K; Häberle H; Kaisers U; Rüddel H; Schädler D; Scheer C; Schreiber T; Schürholz T; Simon P; Sommerer A; Schwarzkopf D; Weyland A; Wöbker G; Reinhart K; Bloos F;
J Crit Care; 2015 Apr; 30(2):439.e1-6. PubMed ID: 25466313
[TBL] [Abstract][Full Text] [Related]
54. Impact of duration of hypotension prior to norepinephrine initiation in medical intensive care unit patients with septic shock: A prospective observational study.
Patel JJ; Kurman JS; Biesboer A; Taha H; Katz M; Szabo A; Simpson SQ; Jacobs ER
J Crit Care; 2017 Aug; 40():178-183. PubMed ID: 28412642
[TBL] [Abstract][Full Text] [Related]
55. Vasopressor treatment and mortality following nontraumatic subarachnoid hemorrhage: a nationwide electronic health record analysis.
Williams G; Maroufy V; Rasmy L; Brown D; Yu D; Zhu H; Talebi Y; Wang X; Thomas E; Zhu G; Yaseen A; Miao H; Leon Novelo L; Zhi D; DeSantis SM; Zhu H; Yamal JM; Aguilar D; Wu H
Neurosurg Focus; 2020 May; 48(5):E4. PubMed ID: 32357322
[TBL] [Abstract][Full Text] [Related]
56. High-dose vasopressin is not superior to norepinephrine in septic shock.
Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
[TBL] [Abstract][Full Text] [Related]
57. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.
Annane D; Vignon P; Renault A; Bollaert PE; Charpentier C; Martin C; Troché G; Ricard JD; Nitenberg G; Papazian L; Azoulay E; Bellissant E;
Lancet; 2007 Aug; 370(9588):676-84. PubMed ID: 17720019
[TBL] [Abstract][Full Text] [Related]
58. Relationship between norepinephrine dose, tachycardia and outcome in septic shock: A multicentre evaluation.
Domizi R; Calcinaro S; Harris S; Beilstein C; Boerma C; Chiche JD; D'Egidio A; Damiani E; Donati A; Koetsier PM; Madden MP; McAuley DF; Morelli A; Pelaia P; Royer P; Shankar-Hari M; Wickboldt N; Zolfaghari P; Singer M
J Crit Care; 2020 Jun; 57():185-190. PubMed ID: 32171905
[TBL] [Abstract][Full Text] [Related]
59. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
[TBL] [Abstract][Full Text] [Related]
60. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
Oba Y; Lone NA
J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
